Mirae Asset Global Investments Co. Ltd. increased its holdings in Bio-Techne Co. (NASDAQ:TECH – Free Report) by 38.4% in the third quarter, according to its most recent filing with the ...

MINNEAPOLIS (AP) — MINNEAPOLIS (AP) — Techne Corp. (TECH) on Wednesday reported fiscal first-quarter earnings of $33.6 million. The Minneapolis-based company said it had net income of 21 cents ...

Bio-Techne Corp. is a global life sciences company providing innovative tools and bioactive reagents for the research and clinical diagnostic communities. Bio-Techne products assist scientific ...

Bio-Techne Trading Up 0.8 % Bio-Techne stock opened at $76.42 on Friday. Bio-Techne Co. has a 52 week low of $55.63 and a 52 week high of $85.57. The company has a debt-to-equity ratio of 0.14, a ...

8 undervalued tech stocks offer attractive prices in a predominantly overvalued sector. Maintaining independence and editorial freedom is essential to our mission of empowering investor success ...

Minneapolis, Minnesota-based Bio-Techne Corporation (TECH) develops, manufactures, and sells life science reagents, instruments, and services for the research, diagnostics, and bioprocessing markets.

MINNEAPOLIS, Nov. 20, 2024 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH), a global life sciences company providing innovative tools and bioactive reagents for the research and clinical ...

RBC Capital analyst Conor McNamara maintained a Hold rating on Bio-Techne (TECH – Research Report) on October 23 and set a price target of $77.00. The company’s shares closed yesterday at $68.37.

Markets Breathe Sigh Of Relief After In-Line Inflation Data: Stocks Rebound As Small Caps, Bonds Soar October inflation data meets expectations with a slight uptick in annual rate, core inflation ...